Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
P. Cho (London, United Kingdom). Determinants of CPAP compliance in bariatric patients with obstructive sleep apnoea. 2284

Member's Comments

No comment yet.

Related content which might interest you: Long-term CPAP compliance in women with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Improving adherence to treatment in patients with obstructive sleep apnoea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004 Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Predicting outcome of nasal surgery in patients with obstructive sleep apnoea Source: Eur Respir J 2008; 32: 246 Year: 2008 Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Adherence to positive airway pressure in non-sleepy patients with obstructive sleep apnoea Source: Eur Respir J 2013; 42: 863-866 Year: 2013 Impact in adherence to CPAP treatment of a specific consultation for patients with severo obstructive sleep apnoea Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020 Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 410s Year: 2006 Safety of cardiac surgery in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 345s Year: 2002 Nasal resistance and CPAP compliance in a large series of obstructive sleep apnea (OSA) patients Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002 Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012